Portfolio company
Abyrx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops and manufactures resorbable hemostatic bone putties and biomaterial devices for surgeons performing orthopaedic, spinal, and cardiothoracic procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bonesupport
This company develops and manufactures injectable bioceramic bone graft substitutes for surgeons and healthcare providers to treat bone voids, defects and infections.
ProFibrix
The company develops and manufactures powdered fibrin sealants for surgeons to control bleeding during and after surgical procedures.
Sealonix
This company develops bioabsorbable hemostatic sealant patches to control surgical bleeding for healthcare providers performing abdominopelvic and orthopaedic procedures.
IBI
This company develops and manufactures biomimetic bone substitutes for orthopaedic and dental surgeons to support bone tissue regeneration.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
SIRAKOSS
SIRAKOSS manufactures nanosynthetic bone graft substitutes for surgeons to facilitate bone repair and regeneration in trauma and spinal surgery patients.
Bioretec
This company manufactures absorbable orthopaedic implants for paediatric and adult surgical patients to eliminate the need for secondary removal surgeries.
